🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Recruitingn/aAges 1 Minute - 18 YearsAllUniversity of California, Davis
NCT00616317 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: * Infants born to mothers with APS * Infants with congenital thrombophilia
💊

What it tests

  • Not listed
📍

Where

1 site
UC Davis Medical Center
Sacramento, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy